Clinical Trial

Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP)

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this cluster randomized controlled trial is to determine the optimal treatment for community aquired pneumonia (CAP). The study compares the effects and side effects of hydrocortisone and prednisolone in patients above 18 years old diagnosed with severe CAP. The main question is whether there is a difference in all cause mortality within thirty days. Participants will be randomized to receive treatment with either hydrocortisone or prednisolone.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-18; most recent amendment 2026-03-16.
Status change: Not Yet Recruiting → Recruiting 2026-03-16
Trial Details
NCT Number NCT06892197
Lead Sponsor Copenhagen Respiratory Research
Conditions Community Acquired Pneumonia (CAP)
Enrollment 1,600 participants
Start Date 2026-03-10
Primary Completion 2030-08-01 (estimated)
Study Completion 2030-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-18